Study shows encouraging therapeutic options for patients with relapsed multiple myeloma
Samir Parekh, MD, discusses his study showing encouraging therapeutic options for patients with a type of blood cancer known as multiple myeloma after first-line treatment with bispecific antibodies fails.
![Test tubes](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-7.jpg)
Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race
Sep 29, 2023 View All Press Releases![Researcher using microscope](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-17.jpg)
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
Nov 04, 2022 View All Press Releases![New York skyscrapers](/files/MSHealth/Assets/Global/Newsroom/2021/ISMMS-Spotlight-Placeholder-2col-770x420-3.jpg)
Potentially Serious Side Effect Seen in Patient after Immunotherapy
Dec 10, 2021 View All Press Releases